Health TrialsbyHealthPanel

Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

ConditionsDyslipidemiasLipid TestingMyocardial Infarction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMontreal Heart Institute

About this trial

Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization.

It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute.

Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission.

Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients ≥18 years old

Hospitalized at the Cardiac Care Unit for Myocardial Infarction (either NSTEMI or STEMI)

Lipid panel performed on day 0 of admission

Willing to provide informed consent

Disqualifiers

None

Trial population

Adult patients hospitalized at the Cardiac Care Unit at the Montreal Heart Institute.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Lipid panel

    Diagnostic test

    Lipid panel measuring levels of LDL, non-HDL and apoB

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Variation in LDL

Evaluation of the variation in LDL levels during a hospital admission for myocardial infarction

Time frame
Day 0 to day 2

Secondary outcomes

1

Variation in non-HDL and apoB

Evaluation of the variation in non-HDL and apoB levels during a hospital admission for myocardial infarction

Time frame
Day 0 to day 2
2

Evaluation of intensification threshold

Among the subgroup of patients who are already treated with lipid-lowering therapy at the time of admission, the proportion of patients with a LDL, non-HDL or apoB value above the intensification threshold

Time frame
Day 0 to day 2

Other outcomes

1

Repeat lipid panel after discharge

Evaluation of the proportion of patients discharged after myocardial infarction who undergo a repeat lipid panel after discharge

Time frame
4-6 weeks
2

Evaluation of intensification threshold after discharge

Evaluation of the proportion of patients discharged after MI with a LDL, non-HDL or apoB value above the intensification threshold after discharge

Time frame
4-6 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Montreal Heart Institute

Lead sponsor

Novartis Pharmaceuticals

Collaborator

Source ClinicalTrials.gov
Apply now